Caspase-10 Inhibits ATP-citrate Lyase-mediated Metabolic and Epigenetic Reprogramming to Suppress Tumorigenesis
Overview
Authors
Affiliations
Caspase-10 belongs to the class of initiator caspases and is a close homolog of caspase-8. However, the lack of caspase-10 in mice and limited substrate repertoire restricts the understanding of its physiological functions. Here, we report that ATP-citrate lyase (ACLY) is a caspase-10 substrate. Caspase-10 cleaves ACLY at the conserved Asp1026 site under conditions of altered metabolic homeostasis. Cleavage of ACLY abrogates its enzymatic activity and suppresses the generation of acetyl-CoA, which is critical for lipogenesis and histone acetylation. Thus, caspase-10-mediated ACLY cleavage results in reduced intracellular lipid levels and represses GCN5-mediated histone H3 and H4 acetylation. Furthermore, decline in GCN5 activity alters the epigenetic profile, resulting in downregulation of proliferative and metastatic genes. Thus caspase-10 suppresses ACLY-promoted malignant phenotype. These findings expand the substrate repertoire of caspase-10 and highlight its pivotal role in inhibiting tumorigenesis through metabolic and epigenetic mechanisms.
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.
Xie X, Liu W, Yuan Z, Chen H, Mao W Mol Cancer. 2025; 24(1):71.
PMID: 40057791 PMC: 11889836. DOI: 10.1186/s12943-025-02269-y.
Shi L, Chen H, Zhang Y, An D, Qin M, Yu W EMBO J. 2025; 44(5):1442-1463.
PMID: 39824985 PMC: 11876347. DOI: 10.1038/s44318-025-00362-y.
Lee S, Park J, Jeong M, Lee D, Kim J, Kim H Animals (Basel). 2024; 14(20).
PMID: 39457969 PMC: 11505232. DOI: 10.3390/ani14203039.
Wang X, Li Y, Hou X, Li J, Ma X Cell Commun Signal. 2024; 22(1):436.
PMID: 39256811 PMC: 11385155. DOI: 10.1186/s12964-024-01792-7.
ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses.
Kaymak I, Watson M, Oswald B, Ma S, Johnson B, DeCamp L J Exp Med. 2024; 221(9).
PMID: 39150482 PMC: 11329787. DOI: 10.1084/jem.20231820.